Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Journal of Dual Diagnosis
|
August 14, 2012
Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week, Open-Label Trial
Gladys N Pachas, Corinne Cather, Sarah A Pratt, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
October 30, 2020
Double-blind, placebo-controlled, proof-of-concept trial of a kappa-selective opioid receptor antagonist augmentation in treatment-resistant depression
Maurizio Fava, Erica Mazzone, Marlene Freeman, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
June 5, 2021
The effect of single administration of intravenous ketamine augmentation on suicidal ideation in treatment-resistant unipolar depression: Results from a randomized double-blind study
Anna Feeney, Rebecca S Hock, Marlene P Freeman, et al.
Journal of Psychiatric Practice
|
November 19, 2013
Use of mental health services in transition age youth with bipolar disorder
Heather Hower, Brady G Case, Bettina Hoeppner, et al.
Depression and Anxiety
|
January 1, 2019
Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression
Naji C Salloum, Maurizio Fava, Marlene P Freeman, et al.
Journal of Affective Disorders
|
September 9, 2019
Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depression
Naji C Salloum, Maurizio Fava, Rebecca S Hock, et al.
The Journal of Nervous and Mental Disease
|
February 11, 2015
Longitudinal associations between interpersonal relationship functioning and mood episode severity in youth with bipolar disorder
Rebecca S Siegel, Bettina Hoeppner, Shirley Yen, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Journal of Dual Diagnosis
|
August 14, 2012
Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week, Open-Label Trial
Gladys N Pachas, Corinne Cather, Sarah A Pratt, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
October 30, 2020
Double-blind, placebo-controlled, proof-of-concept trial of a kappa-selective opioid receptor antagonist augmentation in treatment-resistant depression
Maurizio Fava, Erica Mazzone, Marlene Freeman, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
June 5, 2021
The effect of single administration of intravenous ketamine augmentation on suicidal ideation in treatment-resistant unipolar depression: Results from a randomized double-blind study
Anna Feeney, Rebecca S Hock, Marlene P Freeman, et al.
Journal of Psychiatric Practice
|
November 19, 2013
Use of mental health services in transition age youth with bipolar disorder
Heather Hower, Brady G Case, Bettina Hoeppner, et al.
Depression and Anxiety
|
January 1, 2019
Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression
Naji C Salloum, Maurizio Fava, Marlene P Freeman, et al.
Journal of Affective Disorders
|
September 9, 2019
Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depression
Naji C Salloum, Maurizio Fava, Rebecca S Hock, et al.
The Journal of Nervous and Mental Disease
|
February 11, 2015
Longitudinal associations between interpersonal relationship functioning and mood episode severity in youth with bipolar disorder
Rebecca S Siegel, Bettina Hoeppner, Shirley Yen, et al.
Page
of 3